134 related articles for article (PubMed ID: 17605696)
1. Trends in medication use for asthma in school-entry children in the Australian Capital Territory, 2000-2005.
Phillips CB; Toyne H; Ciszek K; Attewell RG; Kljakovic M
Med J Aust; 2007 Jul; 187(1):10-3. PubMed ID: 17605696
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
3. Holding chambers versus nebulisers for inhaled steroids in chronic asthma.
Cates CJ; Adams N; Bestall J
Cochrane Database Syst Rev; 2001; (2):CD001491. PubMed ID: 11405994
[TBL] [Abstract][Full Text] [Related]
4. Nebulizer use in inner-city children with asthma: morbidity, medication use, and asthma management practices.
Butz AM; Eggleston P; Huss K; Kolodner K; Rand C
Arch Pediatr Adolesc Med; 2000 Oct; 154(10):984-90. PubMed ID: 11030849
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological management of children's asthma in general practice: findings from a community-based cross-sectional survey in Auckland, New Zealand.
Crengle S; Robinson E; Grant C; Arroll B
N Z Med J; 2011 Nov; 124(1346):44-56. PubMed ID: 22143852
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
7. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ; Clark DJ; McFarlane LC
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[TBL] [Abstract][Full Text] [Related]
10. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
[TBL] [Abstract][Full Text] [Related]
11. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
Doull I; Price D; Thomas M; Hawkins N; Stamuli E; Tabberer M; Gosden T; Rudge H
Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of nebulized budesonide inhalation suspension in a child with asthma.
Skoner DP; Angelini BL; Friday G; Gentile D
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):210-4. PubMed ID: 10518848
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications.
McLaughlin T; Leibman C; Patel P; Camargo CA
Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731
[TBL] [Abstract][Full Text] [Related]
15. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
17. Children in the ACT with asthma--are they taking preventer medication according to guidelines?
Brown M; Phillips CB; Ciszek K; Burton D; Attewell R; McDonald T; Dwan K
Aust Fam Physician; 2010 Mar; 39(3):146-9. PubMed ID: 20369117
[TBL] [Abstract][Full Text] [Related]
18. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
[TBL] [Abstract][Full Text] [Related]
19. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
Wales D; Makker H; Kane J; McDowell P; O'Driscoll BR
Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
